Close Menu
Home » NRGene, RCK Partner to Develop Medical Cannabis DNA Biomarkers

NRGene, RCK Partner to Develop Medical Cannabis DNA Biomarkers

Sep 04, 2018
|
staff reporter

NEW YORK (GenomeWeb) — NRGene said today that it has partnered with Israeli cannabis production company RCK to develop DNA-based biomarkers for medical cannabis breeding and strain identification.

Under the terms of the deal, the partners will use NRGene's computational tools to develop the biomarkers for commercial use. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Medical Test for Tax Reasons

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Little More Regulation Wanted

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Act Proposed to Combat Interference

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

PLOS Studies Examine Genes Co-Expressed in Depression, More

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

What's Popular?

In Informatics

  1. Atos Selected to Build Data Infrastructure for French Sequencing Program

  2. Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round

  3. Arbor Biosciences, Curio Genomics Form Wheat Genome Analysis Alliance

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.